Tag
A U.S. health group has become the first cleared to use AI for writing initial skin disease prescriptions, marking the first end-to-end AI doctor operating in a regulated clinical setting.
The FDA has approved Rasonque (daraxonrasib), a first-in-class RAS inhibitor, for the treatment of metastatic pancreatic cancer, demonstrating improved overall survival in clinical trials.
Moderna's mRNA flu vaccine mFLUSIVA received FDA approval for adults over 50, marking the first mRNA-based flu shot. However, uncertainty remains due to the CDC advisory panel being defunct amid litigation, affecting coverage recommendations.
Moderna announced FDA approval of mFLUSIVA (mRNA-1010), a seasonal influenza vaccine for adults 50 and older, following unanimous advisory committee recommendations.
This article provides an overview of the current landscape of AI-enabled medical devices that have received FDA approval, highlighting trends and regulatory progress in healthcare technology.